Press Releases

Date Title and Summary Additional Formats
Toggle Summary Minerva Neurosciences Names Michael Davidson, M.D. as Chief Medical Officer View HTML
Toggle Summary Minerva Neurosciences' Clinical Data Featured at The American College of Neuropsychopharmacology Annual Meeting View HTML
Toggle Summary Minerva Neurosciences to Present at Jefferies 2016 London Healthcare Conference on November 17, 2016 View HTML
Toggle Summary Minerva Neurosciences Reports Third Quarter 2016 Financial Results and Business Updates
Management to host conference call today at 8:30 a.m. Eastern Time
View HTML
Toggle Summary Minerva Neurosciences to Report Third Quarter 2016 Financial Results and Business Updates on November 3, 2016 View HTML
Toggle Summary Minerva Neurosciences Announces Positive Data From Six-Month Extension of Phase IIb Trial of MIN-101 Monotherapy in Schizophrenia View HTML
Toggle Summary Minerva Neurosciences Announces Acceptance of Presentations of Clinical Data With MIN-101 and MIN-117 at American College of Neuropsychopharmacology Annual Meeting
MIN-101 to be highlighted in oral presentation
View HTML
Toggle Summary Minerva Neurosciences Provides Update on MIN-101 and MIN-117 Clinical Programs View HTML
Toggle Summary Minerva Neurosciences to Present at 23rd Annual NewsMakers in the Biotech Industry Conference on September 9, 2016 View HTML
Toggle Summary Minerva Neurosciences Reports Second Quarter 2016 Financial Results and Business Updates View HTML